Amalgamated Bank Akebia Therapeutics, Inc. Transaction History

Amalgamated Bank

$12.2 Billion
Q4 2024

A detailed history of Amalgamated Bank transactions in Akebia Therapeutics, Inc. stock. As of the latest transaction made, Amalgamated Bank holds 7,197 shares of AKBA stock, worth $15,113. This represents 0.0% of its overall portfolio holdings.

Number of Shares

7,197

Previous 7,197 -0.0%

Holding current value

$15,113

Previous $10,000 40.0%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	BUY	$0.86 - $1.63 $6,189 - $11,731	7,197 New	7,197 $7,000
Q2 2022 Aug 15, 2022	SELL	$0.32 - $0.67 $7,757 - $16,241	-24,241 Closed	0 $0
Q1 2022 Jun 30, 2022	SELL	$0.72 - $2.93 $1,319 - $5,367	-1,832 Reduced 7.03%	24,241 $17,000
Q4 2021 Feb 15, 2022	BUY	$2.26 - $3.34 $2,350 - $3,473	1,040 Added 4.15%	26,073 $59,000
Q3 2021 Oct 29, 2021	SELL	$2.35 - $3.88 $1,720 - $2,840	-732 Reduced 2.84%	25,033 $72,000
Q2 2021 Aug 16, 2021	BUY	$2.83 - $4.2 $9,568 - $14,200	3,381 Added 15.1%	25,765 $98,000
Q4 2020 Feb 12, 2021	BUY	$2.22 - $3.78 $261 - $446	118 Added 0.53%	22,384 $62,000
Q3 2020 Oct 30, 2020	BUY	$2.39 - $13.08 $3,455 - $18,913	1,446 Added 6.95%	22,266 $56,000
Q2 2020 Aug 10, 2020	BUY	$6.67 - $13.58 $15,967 - $32,510	2,394 Added 12.99%	20,820 $283,000
Q1 2020 May 13, 2020	SELL	$4.1 - $10.24 $3,197 - $7,987	-780 Reduced 4.06%	18,426 $140,000
Q4 2019 Feb 13, 2020	BUY	$3.16 - $6.73 $5,381 - $11,461	1,703 Added 9.73%	19,206 $121,000
Q3 2019 Nov 13, 2019	SELL	$3.55 - $5.4 $745 - $1,134	-210 Reduced 1.19%	17,503 $69,000
Q2 2019 Aug 14, 2019	BUY	$4.1 - $8.05 $17,777 - $34,904	4,336 Added 32.41%	17,713 $86,000
Q1 2019 May 15, 2019	BUY	$5.41 - $8.73 $2,369 - $3,823	438 Added 3.39%	13,377 $110,000
Q4 2018 Feb 15, 2019	BUY	$5.39 - $9.15 $69,741 - $118,391	12,939 New	12,939 $72,000

Others Institutions Holding AKBA

# of Institutions

129

Shares Held

62.8M

Call Options Held

50.6K

Put Options Held

203K

View Full List

About Akebia Therapeutics, Inc.

Ticker AKBA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 183,848,992
Market Cap $386M
Description
Akebia Therapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics for patients with kidney diseases. The company's lead product investigational product candidate is vadadustat, an oral therapy, which is in Phase III development for the treatment of anemia due to chronic kidney disease (CKD) ...

More about AKBA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Amalgamated Bank, based on Form 13F filings with the SEC.

News

Stay updated on Amalgamated Bank with notifications on news.

Account

Amalgamated Bank Akebia Therapeutics, Inc. Transaction History